Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming

Author:

Vaziri H1,Chapman KB2,Guigova A3,Teichroeb J4,Lacher MD5,Sternberg H6,Singec I7,Briggs L8,Wheeler J9,Sampathkumar J10,Gonzalez R11,Larocca D12,Murai J13,Snyder E14,Andrews WH15,Funk WD16,West MD17

Affiliation:

1. Homayoun Vaziri Ontario Cancer Institute/PMH, University of Toronto, Canada

2. Karen B Chapman BioTime, Inc., Alameda, CA 94502, USA

3. Andriana Guigova Ontario Cancer Institute/PMH, University of Toronto, Canada

4. Jonathan Teichroeb Ontario Cancer Institute/PMH, University of Toronto, Canada

5. Markus D Lacher BioTime, Inc., Alameda, CA 94502, USA

6. Hal Sternberg BioTime, Inc., Alameda, CA 94502, USA

7. Ilyas Singec Burnham Institute for Medical Research, La Jolla, CA, USA

8. Laura Briggs Sierra Sciences, Reno NV, USA

9. Jessica Wheeler Sierra Sciences, Reno NV, USA

10. Janani Sampathkumar BioTime, Inc., Alameda, CA 94502, USA

11. Rodolfo Gonzalez The Scripps Research Institute, La Jolla, CA 92037, USA

12. David Larocca Mandala Biosciences, LLC, La Jolla, CA, USA

13. James Murai BioTime, Inc., Alameda, CA 94502, USA

14. Evan Snyder Burnham Institute for Medical Research, La Jolla, CA, USA

15. William H Andrews Sierra Sciences, Reno NV, USA

16. Walter D Funk BioTime, Inc., Alameda, CA 94502, USA

17. Michael D West BioTime, Inc., Alameda, CA 94502, USA.

Abstract

Aim: To determine whether transcriptional reprogramming is capable of reversing the developmental aging of normal human somatic cells to an embryonic state. Materials & methods: An isogenic system was utilized to facilitate an accurate assessment of the reprogramming of telomere restriction fragment (TRF) length of aged differentiated cells to that of the human embryonic stem (hES) cell line from which they were originally derived. An hES-derived mortal clonal cell strain EN13 was reprogrammed by SOX2, OCT4 and KLF4. The six resulting induced pluripotent stem (iPS) cell lines were surveyed for telomere length, telomerase activity and telomere-related gene expression. In addition, we measured all these parameters in widely-used hES and iPS cell lines and compared the results to those obtained in the six new isogenic iPS cell lines. Results: We observed variable but relatively long TRF lengths in three widely studied hES cell lines (16.09–21.1 kb) but markedly shorter TRF lengths (6.4–12.6 kb) in five similarly widely studied iPS cell lines. Transcriptome analysis comparing these hES and iPS cell lines showed modest variation in a small subset of genes implicated in telomere length regulation. However, iPS cell lines consistently showed reduced levels of telomerase activity compared with hES cell lines. In order to verify these results in an isogenic background, we generated six iPS cell clones from the hES-derived cell line EN13. These iPS cell clones showed initial telomere lengths comparable to the parental EN13 cells, had telomerase activity, expressed embryonic stem cell markers and had a telomere-related transcriptome similar to hES cells. Subsequent culture of five out of six lines generally showed telomere shortening to lengths similar to that observed in the widely distributed iPS lines. However, the clone EH3, with relatively high levels of telomerase activity, progressively increased TRF length over 60 days of serial culture back to that of the parental hES cell line. Conclusion: Prematurely aged (shortened) telomeres appears to be a common feature of iPS cells created by current pluripotency protocols. However, the spontaneous appearance of lines that express sufficient telomerase activity to extend telomere length may allow the reversal of developmental aging in human cells for use in regenerative medicine.

Publisher

Future Medicine Ltd

Subject

Embryology,Biomedical Engineering

Reference71 articles.

Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3